Cases & Deals

  • Home
  • Practices
  • Amoéba completes €14.7 million private placement of new shares

Share

Amoéba completes €14.7 million private placement of new shares

May 2016

Client(s) Amoéba SAS

Jones Day represented Amoéba SAS, a developer of sustainable organic biocide capable of mitigating bacterial risk in water systems, in connection with the €14.7 million (US$16.5 million) private placement of new shares to European and American investors.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.